Authors:
Wandt, H
Frank, M
Denzel, T
Aulitzky, W
Bodenstein, H
Brack, N
Duerk, H
Engberding, R
Fauser, A
Geer, T
Germann, B
Gramatzki, M
Kaesberger, J
Kisro, J
Knigge, O
Kochling, G
Kuse, R
Link, H
Neubauer, A
Ohl, S
Pfluger, R
Saal, J
Schakel, U
Schalk, K
Schmidt, H
Soucek, S
Wagner, T
Wilms, K
Winter, R
Ehninger, G
Citation: H. Wandt et al., The 10.000/mu l morning trigger for prophylactic platelet transfusion is safe: Prospective experience in 411 AML patients, HEMAT BLOOD, 40, 2001, pp. 488-490
Authors:
Ganser, A
Heil, G
Seipelt, G
Hofmann, W
Fischer, JT
Langer, W
Brockhaus, W
Kolbe, K
Ittel, H
Brack, N
Fuhr, HG
Knuth, P
Hoffken, K
Bergmann, L
Hoelzer, D
Citation: A. Ganser et al., Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML), ANN HEMATOL, 79(1), 2000, pp. 30-35
Authors:
Hentrich, M
Rockstroh, J
Sandner, R
Brack, N
Hartenstein, R
Citation: M. Hentrich et al., Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature, ANN ONCOL, 11(2), 2000, pp. 195-200
Authors:
Gesierich, W
Munker, R
Geiersberger, U
Pohlmann, H
Brack, N
Hartenstein, R
Citation: W. Gesierich et al., Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia, ONKOLOGIE, 23(6), 2000, pp. 584-588